| Douglas Kahn, DO | |
|
24 Hospital Ave, Danbury, CT 06810-6099 | |
| (203) 739-7070 | |
| (203) 739-8931 |
| Full Name | Douglas Kahn |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 34 Years |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063431682 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
More than a dozen academic institutions and other partners, including the University of Maryland, are banding together to meet Maryland's growing need for health professionals in medically under-served urban and rural communities, and provide a working model for other states committed to expanding and diversifying their health workforce.
Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse.
When Darin McCloud, 45 from Portsmouth, was told he did not qualify for a gastric bypass, he planned to get fatter to tip the scales at more than 133kg - the weight deemed necessary by his local NHS primary care trust. At present he is eating three-quarters of a loaf of bread, four packets of crisps and bacon rolls each day to put on the weight. He also has diabetes ad he believes that the surgery could get him off the insulin injections.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
› Verified 1 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
More than a dozen academic institutions and other partners, including the University of Maryland, are banding together to meet Maryland's growing need for health professionals in medically under-served urban and rural communities, and provide a working model for other states committed to expanding and diversifying their health workforce.
Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse.
When Darin McCloud, 45 from Portsmouth, was told he did not qualify for a gastric bypass, he planned to get fatter to tip the scales at more than 133kg - the weight deemed necessary by his local NHS primary care trust. At present he is eating three-quarters of a loaf of bread, four packets of crisps and bacon rolls each day to put on the weight. He also has diabetes ad he believes that the surgery could get him off the insulin injections.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Kahn, DO 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 739-7070 | Douglas Kahn, DO 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 739-7070 |
News Archive
More than a dozen academic institutions and other partners, including the University of Maryland, are banding together to meet Maryland's growing need for health professionals in medically under-served urban and rural communities, and provide a working model for other states committed to expanding and diversifying their health workforce.
Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse.
When Darin McCloud, 45 from Portsmouth, was told he did not qualify for a gastric bypass, he planned to get fatter to tip the scales at more than 133kg - the weight deemed necessary by his local NHS primary care trust. At present he is eating three-quarters of a loaf of bread, four packets of crisps and bacon rolls each day to put on the weight. He also has diabetes ad he believes that the surgery could get him off the insulin injections.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
› Verified 1 days ago
Dr. Shivayogi V Magavi, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
Andrew Keller, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 27 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7155 | |
Mary E. Blackman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Sand Pit Road, 102, Danbury, CT 06810 Phone: 203-749-5700 | |
Nirmalamma S Magavi, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
David D Weinshel, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7173 | |
Dr. Michael Spiegel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 33 Germantown Rd, 1st Floor, Danbury, CT 06810 Phone: 203-794-5600 Fax: 203-794-5611 | |
Michael Cohenuram, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7742 Fax: 203-830-2090 |